Reference: Kaur H et. al., (2019) Classification of early and late stage liver hepatocellular carcinoma
patients from their genomics and epigenomics profiles. PLoS One. 14(9):e0221476.


Analysis of Genomics Data in Patients

This tool allows the analysis of cancer genomics data for a single patient in the form of FPKM value. User can submit the FPKM value of RNA tarnscripts and analyze whether the log2(FPKM) value of the patient is above or below the given threshold. If gene is overexpressed in early stage, and score of patient is above threshold then its chance that the patient is in early stage. Thus, the user can see what is the expression status of each RNA transcript, which can point towards whether the patient is in early or late stage of cancer. For more information please click Help.

Submit csv file in which each number represents the FPKM value derived from mRNA expression of each subject derived from mRNAseq data of the Liver Hepatocellular Carcinoma:



   Example csv file